SCHEMBL5373225

SCHEMBL5373225

CCc1ccc(S(=O)(=O)N(c2ccc(C(C)(C)C)cc2)c2ccc3ocnc3c2)cc1C(=O)OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.36
ALDH1A1 P00352 4/20 0.36
TSHR P16473 1/20 0.36
MAPT P10636 4/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
HIF1A Q16665 1/20 0.33
CTNNB1 P35222 1/20 0.33
WNT3A P56704 1/20 0.33
NR1I2 O75469 3/20 0.33
HDAC3 O15379 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
HCRTR2 O43614 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
GAA P10253 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376782 0.92 GAA (0.36) TP53ALDH1A1TSHRMAPTKMT2A
SCHEMBL5391241 0.90 ALDH1A1 (0.35) TP53ALDH1A1MAPTKMT2AMEN1
SCHEMBL5921908 0.90 TP53 (0.39) TP53ALDH1A1TSHRMAPTKMT2A
SCHEMBL5376744 0.88 ALDH1A1 (0.38) TP53ALDH1A1TSHRMAPTHDAC3
SCHEMBL5921895 0.87 TP53 (0.38) TP53ALDH1A1TSHRMAPTKMT2A
SCHEMBL5368411 0.82 RXRA (0.39) ALDH1A1KMT2AMEN1CTNNB1WNT3A
SCHEMBL5367888 0.82 GAA (0.37) TP53ALDH1A1TSHRMAPTKMT2A
SCHEMBL5370576 0.81 SMN1; SMN2 (0.35) TP53ALDH1A1TSHRKMT2AMEN1
SCHEMBL5368704 0.80 TRPM8 (0.41) ALDH1A1HCRTR2
SCHEMBL5376611 0.79 SMN1; SMN2 (0.34) TP53ALDH1A1KMT2AMEN1CTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TP53 3421/4885ALDH1A1 2956/4885TSHR 400/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD TP53 3528/4885ALDH1A1 2752/4885TSHR 310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.